BioSpace News Archive

BioCapital

Systemic Racism, Access to Care, Poverty and Preexisting conditions Help Fuel U.S. Maternal And Infant Health Crisis, Particularly Devastating For Moms And Babies Of Color

New March Of Dimes Report Card Shows Preterm Birth Rates Climb For 5th Straight Year, Earning The Nation A “C-" Grade Humana Foundation and March of Dimes are partnering in six communities nationwide to implement strategies to improve maternal and infant health

November 16, 2020
·
8 min read
Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients

Patient Blood Management with Masimo SpHb Increased Transfusion Appropriateness and Decreased RBC Units Transfused per Patient

November 16, 2020
·
10 min read
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases

R&D collaboration building on Lead Pharma’s expertise in the discovery, design and optimization of small molecule treatments

November 16, 2020
·
3 min read
Business

Terns Pharmaceuticals Appoints Industry Veteran Bryan Yoon as Chief Operating Officer and General Counsel

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases, announced the appointment of Bryan Yoon as Chief Operating Officer and General Counsel.

November 16, 2020
·
2 min read
Business

Athersys Announces Three Appointments to Board of Directors

Addition deepens board expertise to prepare for future growth and potential commercialization of MultiStem®

November 16, 2020
·
12 min read
Development of Blood-Based Alzheimer’s Prognostic Propels Diadem to Finalist Status for Both the Gaetano Marzotto Company Prize and 2030 Social Impact Special Prize

Prestigious Awards Celebrate Entrepreneurial Company Innovation and Pioneering New Products Supporting UN Sustainable Development Goals

November 16, 2020
·
5 min read
Policy

Lupin Announces FDA Filing Acceptance of Supplemental New Drug Application for Solosec® (secnidazole) for the Treatment of Trichomoniasis

Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of Lupin Limited, announced that the U.S. Food and Drug Administration has accepted their supplemental New Drug Application for Solosec® for the treatment of trichomoniasis in adults and adolescents.

November 16, 2020
·
8 min read
Genetown

PureTech to Present at Three Upcoming Investor Conferences - Nov 16, 2020

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced that members of the Management Team will present at the following upcoming virtual investor conferences.

November 16, 2020
·
3 min read
Deals

Ocuphire Pharma Announces Expansion of Global Patents for Nyxol® and $1.7 Million NIH Grants for APX3330 Program

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced milestones for patents and grants on both its lead drug candidates Nyxol and APX3330.

November 16, 2020
·
5 min read
Genetown

PerkinElmer Launches New HPLC, UHPLC and Next Generation Software Solution

LC 300™ platform and SimplicityChrom™ software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance

November 16, 2020
·
3 min read